499 related articles for article (PubMed ID: 17378849)
1. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
[TBL] [Abstract][Full Text] [Related]
2. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
Brooks JD; Weinstein M; Lin X; Sun Y; Pin SS; Bova GS; Epstein JI; Isaacs WB; Nelson WG
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):531-6. PubMed ID: 9641498
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG; Qian J; Maihle NJ
Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
7. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
Zhou T; Xu C; He M; Sun Y
Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of microdissected specimens.
Yasunaga Y; Shin M; Fujita MQ; Nonomura N; Miki T; Okuyama A; Aozasa K
Lab Invest; 1998 Oct; 78(10):1275-9. PubMed ID: 9800953
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
[TBL] [Abstract][Full Text] [Related]
12. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
13. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology of prostatic intraepithelial neoplasia.
Bostwick DG; Pacelli A; Lopez-Beltran A
Prostate; 1996 Aug; 29(2):117-34. PubMed ID: 8700801
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
[TBL] [Abstract][Full Text] [Related]
16. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
[TBL] [Abstract][Full Text] [Related]
17. Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 Aug; 67(11):1143-51. PubMed ID: 17503471
[TBL] [Abstract][Full Text] [Related]
18. Changes in the normal-looking epithelium in prostates with PIN or cancer.
Colanzi P; Santinelli A; Mazzucchelli R; Pomante R; Montironi R
Adv Clin Path; 1999 Oct; 3(4):129-34. PubMed ID: 10936890
[TBL] [Abstract][Full Text] [Related]
19. [Detection of telomerase activity in prostate needle-biopsy samples].
Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
[TBL] [Abstract][Full Text] [Related]
20. Changes in chromatin phenotype predict the response to hormonal deprivation therapy in patients with prostate cancer.
Mohamed M; Greif PA; Diamond J; Sharafeldin O; Maxwell P; Montironi R; O'Brien A; Young M; Hamilton PW
BJU Int; 2009 Feb; 103(3):391-8. PubMed ID: 19021609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
